Here is the outline explained in the previous video. If you have any questions, post them in the comments section at the bottom of the page.
The alternative pathway
Although the alternative pathway is probably the oldest of the pathways, it has this name because it was discovered second, after the classical pathway had been described. Its main features are the possibility of spontaneous activation and the formation of an alternative C3 convertase, different from that of the other pathways. The C3 convertase of the alternative pathway is composed of C3b bound to Bb, the fragment resulting from proteolysis of factor B. This C3 convertase, designated C3bBb, occupies a key place in complement activation, since it is able to perpetuate the production of C3b. This means that once C3b has formed, by any of the pathways, the alternative pathway acts as an amplification loop, rapidly increasing the production of C3b (Figure 11.7).
The alternative pathway can be activated by two mechanisms. The first is through the action of the lectin pathway or the classical pathway (Figure 11.8). The C3b fragments generated in these pathways bind covalently to the microbial surface and factor
B binds to them. This binding produces a conformational change in factor B, allowing the plasma protease called factor D to cleave it to produce Ba and Bb. Bb remains associated with C3b, forming the solid-phase C3 convertase C3bBb. The second mechanism is based on the phenomenon of spontaneous hydrolysis of the thioester bond in C3 to form C3(H2O), as shown in Figure 11.9. C3(H2O) binds to factor B, which is then cleaved by factor D to produce a short-half-life fluid-phase C3 convertase called C3(H2O)Bb. Despite its short half-life, this convertase is able to cleave many C3 molecules, increasing the formation of C3b and amplifying the response.
The C3 convertases of the alternative pathway have a short half-life on their own. However, they can be stabilised by binding to the plasma protein called properdin or factor P. Properdin is synthesised in neutrophils, which store it in their secondary granules and release it when they are activated in the presence of pathogens.

(Reproduced from Murphy K et al. (2012) Janeway’s Immunobiology (8th Ed.) Garland Science, New York.)

(Reproduced from Murphy K et al. (2012) Janeway’s Immunobiology (8th Ed.) Garland Science, New York.)


(Reproduced from Murphy K et al. (2012) Janeway’s Immunobiology (8th Ed.) Garland Science, New York.)